Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Periprocedural acute haemodynamic decompensation during substrate-based ablation of scar-related ventricular tachycardia: a rare and unpredictable event

P. Stojadinović, D. Wichterle, P. Peichl, R. Čihák, B. Aldhoon, E. Borišincová, P. Štiavnický, J. Hašková, A. Ševčík, J. Kautzner

. 2024 ; 26 (6) : . [pub] 20240603

Language English Country England, Great Britain

Document type Journal Article

Grant support
LX22NPO5104 National Institute for Research of Metabolic and Cardiovascular Diseases
European Union, NextGenerationEU
00023001 project (Ministry of Health, Czech Republic) for development of research organization

AIMS: Patients with structural heart disease (SHD) undergoing catheter ablation (CA) for ventricular tachycardia (VT) are at considerable risk of periprocedural complications, including acute haemodynamic decompensation (AHD). The PAINESD score was proposed to predict the risk of AHD. The goal of this study was to validate the PAINESD score using the retrospective analysis of data from a large-volume heart centre. METHODS AND RESULTS: Patients who had their first radiofrequency CA for SHD-related VT between August 2006 and December 2020 were included in the study. Procedures were mainly performed under conscious sedation. Substrate mapping/ablation was performed primarily during spontaneous rhythm or right ventricular pacing. A purposely established institutional registry for complications of invasive procedures was used to collect all periprocedural complications that were subsequently adjudicated using the source medical records. Acute haemodynamic decompensation triggered by CA procedure was defined as intraprocedural or early post-procedural (<12 h) development of acute pulmonary oedema or refractory hypotension requiring urgent intervention. The study cohort consisted of 1124 patients (age, 63 ± 13 years; males, 87%; ischaemic cardiomyopathy, 67%; electrical storm, 25%; New York Heart Association Class, 2.0 ± 1.0; left ventricular ejection fraction, 34 ± 12%; diabetes mellitus, 31%; chronic obstructive pulmonary disease, 12%). Their PAINESD score was 11.4 ± 6.6 (median, 12; interquartile range, 6-17). Acute haemodynamic decompensation complicated the CA procedure in 13/1124 = 1.2% patients and was not predicted by PAINESD score with AHD rates of 0.3, 1.8, and 1.1% in subgroups by previously published PAINESD terciles (<9, 9-14, and >14). However, the PAINESD score strongly predicted mortality during the follow-up. CONCLUSION: Primarily substrate-based CA of SHD-related VT performed under conscious sedation is associated with a substantially lower rate of AHD than previously reported. The PAINESD score did not predict these events. The application of the PAINESD score to the selection of patients for pre-emptive mechanical circulatory support should be reconsidered.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24013581
003      
CZ-PrNML
005      
20240910092547.0
007      
ta
008      
240725s2024 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1093/europace/euae145 $2 doi
035    __
$a (PubMed)38864730
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Stojadinović, Predrag $u Institute for Clinical and Experimental Medicine, Vídeňská 1958/9 Prague 140 21, Czechia $u First Faculty of Medicine, Institute of Physiology, Charles University, Prague, Czechia $1 https://orcid.org/0000000214875823
245    10
$a Periprocedural acute haemodynamic decompensation during substrate-based ablation of scar-related ventricular tachycardia: a rare and unpredictable event / $c P. Stojadinović, D. Wichterle, P. Peichl, R. Čihák, B. Aldhoon, E. Borišincová, P. Štiavnický, J. Hašková, A. Ševčík, J. Kautzner
520    9_
$a AIMS: Patients with structural heart disease (SHD) undergoing catheter ablation (CA) for ventricular tachycardia (VT) are at considerable risk of periprocedural complications, including acute haemodynamic decompensation (AHD). The PAINESD score was proposed to predict the risk of AHD. The goal of this study was to validate the PAINESD score using the retrospective analysis of data from a large-volume heart centre. METHODS AND RESULTS: Patients who had their first radiofrequency CA for SHD-related VT between August 2006 and December 2020 were included in the study. Procedures were mainly performed under conscious sedation. Substrate mapping/ablation was performed primarily during spontaneous rhythm or right ventricular pacing. A purposely established institutional registry for complications of invasive procedures was used to collect all periprocedural complications that were subsequently adjudicated using the source medical records. Acute haemodynamic decompensation triggered by CA procedure was defined as intraprocedural or early post-procedural (<12 h) development of acute pulmonary oedema or refractory hypotension requiring urgent intervention. The study cohort consisted of 1124 patients (age, 63 ± 13 years; males, 87%; ischaemic cardiomyopathy, 67%; electrical storm, 25%; New York Heart Association Class, 2.0 ± 1.0; left ventricular ejection fraction, 34 ± 12%; diabetes mellitus, 31%; chronic obstructive pulmonary disease, 12%). Their PAINESD score was 11.4 ± 6.6 (median, 12; interquartile range, 6-17). Acute haemodynamic decompensation complicated the CA procedure in 13/1124 = 1.2% patients and was not predicted by PAINESD score with AHD rates of 0.3, 1.8, and 1.1% in subgroups by previously published PAINESD terciles (<9, 9-14, and >14). However, the PAINESD score strongly predicted mortality during the follow-up. CONCLUSION: Primarily substrate-based CA of SHD-related VT performed under conscious sedation is associated with a substantially lower rate of AHD than previously reported. The PAINESD score did not predict these events. The application of the PAINESD score to the selection of patients for pre-emptive mechanical circulatory support should be reconsidered.
650    _2
$a lidé $7 D006801
650    12
$a komorová tachykardie $x chirurgie $x patofyziologie $x etiologie $x diagnóza $7 D017180
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé středního věku $7 D008875
650    12
$a katetrizační ablace $x škodlivé účinky $7 D017115
650    _2
$a retrospektivní studie $7 D012189
650    12
$a hemodynamika $7 D006439
650    _2
$a jizva $x patofyziologie $7 D002921
650    _2
$a senioři $7 D000368
650    _2
$a hypotenze $x etiologie $x patofyziologie $x diagnóza $7 D007022
650    _2
$a plicní edém $x etiologie $x diagnóza $x patofyziologie $7 D011654
650    _2
$a pooperační komplikace $x etiologie $x diagnóza $7 D011183
650    _2
$a rizikové faktory $7 D012307
655    _2
$a časopisecké články $7 D016428
700    1_
$a Wichterle, Dan $u Institute for Clinical and Experimental Medicine, Vídeňská 1958/9 Prague 140 21, Czechia $1 https://orcid.org/0000000204485143 $7 xx0101417
700    1_
$a Peichl, Petr $u Institute for Clinical and Experimental Medicine, Vídeňská 1958/9 Prague 140 21, Czechia $1 https://orcid.org/0000000256250071 $7 xx0092197
700    1_
$a Čihák, Robert $u Institute for Clinical and Experimental Medicine, Vídeňská 1958/9 Prague 140 21, Czechia
700    1_
$a Aldhoon, Bashar $u Institute for Clinical and Experimental Medicine, Vídeňská 1958/9 Prague 140 21, Czechia $1 https://orcid.org/000000021845847X
700    1_
$a Borišincová, Eva $u Institute for Clinical and Experimental Medicine, Vídeňská 1958/9 Prague 140 21, Czechia $1 https://orcid.org/000000029756283X $7 xx0322160
700    1_
$a Štiavnický, Petr $u Institute for Clinical and Experimental Medicine, Vídeňská 1958/9 Prague 140 21, Czechia $1 https://orcid.org/0000000160633545
700    1_
$a Hašková, Jana $u Institute for Clinical and Experimental Medicine, Vídeňská 1958/9 Prague 140 21, Czechia $1 https://orcid.org/0000000337748672
700    1_
$a Ševčík, Adam $u Institute for Clinical and Experimental Medicine, Vídeňská 1958/9 Prague 140 21, Czechia $1 https://orcid.org/000900059829758X
700    1_
$a Kautzner, Josef $u Institute for Clinical and Experimental Medicine, Vídeňská 1958/9 Prague 140 21, Czechia $1 https://orcid.org/0000000216326182 $7 xx0037112
773    0_
$w MED00149837 $t Europace $x 1532-2092 $g Roč. 26, č. 6 (2024)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38864730 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240725 $b ABA008
991    __
$a 20240910092544 $b ABA008
999    __
$a ok $b bmc $g 2143406 $s 1225447
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 26 $c 6 $e 20240603 $i 1532-2092 $m Europace $n Europace $x MED00149837
GRA    __
$a LX22NPO5104 $p National Institute for Research of Metabolic and Cardiovascular Diseases
GRA    __
$p European Union, NextGenerationEU
GRA    __
$a 00023001 $p project (Ministry of Health, Czech Republic) for development of research organization
LZP    __
$a Pubmed-20240725

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...